View More View Less
  • 1 Niigata University of Pharmacy and Applied Life Sciences Department of Clinical Pharmacology 265-1 Higashijima, Akiha-ku Niigata City Japan
  • | 2 University of Connecticut School of Medicine Cardiovascular Research Center Farmington USA
  • | 3 Lightlab Imaging, Inc. Westford USA
  • | 4 Washington University School of Medicine Department of Internal Medicine, Center for Cardiovascular Research St. Louis USA
  • | 5 Niigata University Graduate School of Medical and Dental Sciences Third Department of Medicine Niigata Japan
  • | 6 Niigata University Graduate School of Medical and Dental Sciences First Department of Medicine Niigata Japan
  • | 7 Niigata University of Pharmacy and Applied Life Sciences Department of Clinical Pharmacology, Faculty of Pharmaceutical Sciences 265-1 Higashijima, Akiha-ku Niigata city 956-8603 Japan
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $752.00

Cardiovascular disease is a leading cause of death worldwide. Diabetes mellitus is a well-known and important risk factor for cardiovascular diseases. The occurrence of diabetic cardiomyopathy is independent of hypertension, coronary artery disease, or any other known cardiac diseases. There is growing evidence that excess generation of highly reactive free radicals, largely due to hyperglycemia, causes oxidative stress, which further exacerbates the development and progression of diabetes and its complications. Diabetic cardiomyopathy is characterized by morphologic and structural changes in the myocardium and coronary vasculature mediated by the activation of various signaling pathways. Myocardial apoptosis, hypertrophy and fibrosis are the most frequently proposed mechanisms to explain cardiac changes in diabetic cardiomyopathy. Mammalian 14-3-3 proteins are dimeric phosphoserine-binding proteins that participate in signal transduction and regulate several aspects of cellular biochemistry. 14-3-3 protein regulates diabetic cardiomyopathy via multiple signaling pathways. This review focuses on emerging evidence suggesting that 14-3-3 protein plays a key role in the pathogenesis of the cardiovascular complications of diabetes, which underlie the development and progression of diabetic cardiomyopathy.

  • Aitken A, Howell S, Jones D, Madrazo J, Martin H, Patel Y, Robinson K: Post-translationally modified 14-3-3 isoforms and inhibition of protein kinase C. Mol. Cell. Biochem. 149–150, 41–49 (1995)

    Robinson K. , 'Post-translationally modified 14-3-3 isoforms and inhibition of protein kinase C ' (1995 ) 149–150 Mol. Cell. Biochem. : 41 -49.

    • Search Google Scholar
  • Alici B, Gumustas MK, Ozkara H, Akkus E, Demirel G, Yencilek F, Hattat H: Apoptosis in the erectile tissues of diabetic and healthy rats. BJU Int. 85, 326–329 (2000)

    Hattat H. , 'Apoptosis in the erectile tissues of diabetic and healthy rats ' (2000 ) 85 BJU Int. : 326 -329.

    • Search Google Scholar
  • Baynes JW: Role of oxidative stress in development of complications in diabetes. Diabetes 40, 405–412 (1991)

    Baynes J.W. , 'Role of oxidative stress in development of complications in diabetes ' (1991 ) 40 Diabetes : 405 -412.

    • Search Google Scholar
  • Bonow RO, Gheorghiade M: The diabetes epidemic: a national and global crisis. Am. J. Med. 116Suppl 5A, 2S–10S (2004)

    Gheorghiade M. , 'The diabetes epidemic: a national and global crisis ' (2004 ) 116 Am. J. Med. : 2S -10S.

    • Search Google Scholar
  • Brownlee M: The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54, 1615–1625 (2005)

    Brownlee M. , 'The pathobiology of diabetic complications: a unifying mechanism ' (2005 ) 54 Diabetes : 1615 -1625.

    • Search Google Scholar
  • Cai L, Chen S, Evans T, Deng DX, Mukherjee K, Chakrabarti S: Apoptotic germ-cell death and testicular damage in experimental diabetes: prevention by endothelin antagonism. Urol. Res. 28, 342–347 (2000)

    Chakrabarti S. , 'Apoptotic germ-cell death and testicular damage in experimental diabetes: prevention by endothelin antagonism ' (2000 ) 28 Urol. Res. : 342 -347.

    • Search Google Scholar
  • Cai L, Kang YJ: Cell death and diabetic cardiomyopathy. Cardiovasc. Toxicol. 3, 219–228 (2003)

    Kang Y.J. , 'Cell death and diabetic cardiomyopathy ' (2003 ) 3 Cardiovasc. Toxicol. : 219 -228.

    • Search Google Scholar
  • Cai L, Kang YJ: Oxidative stress and diabetic cardiomyopathy: a brief review. Cardiovasc. Toxicol. 1, 181–193 (2001)

    Kang Y.J. , 'Oxidative stress and diabetic cardiomyopathy: a brief review ' (2001 ) 1 Cardiovasc. Toxicol. : 181 -193.

    • Search Google Scholar
  • Cai L, Li W, Wang G, Guo L, Jiang Y, Kang YJ: Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway. Diabetes 51, 1938–1948 (2002)

    Kang Y.J. , 'Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway ' (2002 ) 51 Diabetes : 1938 -1948.

    • Search Google Scholar
  • Campbell SE, Katwa LC: Angiotensin II stimulated expression of transforming growth factor-beta1 in cardiac fibroblasts and myofibroblasts. J. Mol. Cell. Cardiol. 29, 1947–1958 (1997)

    Katwa L.C. , 'Angiotensin II stimulated expression of transforming growth factor-beta1 in cardiac fibroblasts and myofibroblasts ' (1997 ) 29 J. Mol. Cell. Cardiol. : 1947 -1958.

    • Search Google Scholar
  • Clerk A, Bogoyevitch MA, Anderson MB, Sugden PH: Differential activation of protein kinase C isoforms by endothelin-1 and phenylephrine and subsequent stimulation of p42 and p44 mitogen-activated protein kinases in ventricular myocytes cultured from neonatal rat hearts. J. Biol. Chem. 269, 32848–32857 (1994)

    Sugden P.H. , 'Differential activation of protein kinase C isoforms by endothelin-1 and phenylephrine and subsequent stimulation of p42 and p44 mitogen-activated protein kinases in ventricular myocytes cultured from neonatal rat hearts ' (1994 ) 269 J. Biol. Chem. : 32848 -32857.

    • Search Google Scholar
  • Cook SA, Sugden PH, Clerk A: Activation of c-Jun N-terminal kinases and p38-mitogen-activated protein kinases in human heart failure secondary to ischaemic heart disease. J. Mol. Cell. Cardiol. 31, 1429–1434 (1999)

    Clerk A. , 'Activation of c-Jun N-terminal kinases and p38-mitogen-activated protein kinases in human heart failure secondary to ischaemic heart disease ' (1999 ) 31 J. Mol. Cell. Cardiol. : 1429 -1434.

    • Search Google Scholar
  • Decock JB, Gillespie-Brown J, Parker PJ, Sugden PH, Fuller SJ: Classical, novel and atypical isoforms of PKC stimulate ANF- and TRE/AP-1-regulated-promoter activity in ventricular cardiomyocytes. FEBS Lett. 356, 275–278 (1994)

    Fuller S.J. , 'Classical, novel and atypical isoforms of PKC stimulate ANF- and TRE/AP-1-regulated-promoter activity in ventricular cardiomyocytes ' (1994 ) 356 FEBS Lett. : 275 -278.

    • Search Google Scholar
  • Diwan A, Tran T, Misra A, Mann DL: Inflammatory mediators and the failing heart: a translational approach. Curr. Mol. Med. 3, 161–182 (2003)

    Mann D.L. , 'Inflammatory mediators and the failing heart: a translational approach ' (2003 ) 3 Curr. Mol. Med. : 161 -182.

    • Search Google Scholar
  • Enguita M, DeGregorio-Rocasolano N, Abad A, Trullas R: Glycogen synthase kinase 3 activity mediates neuronal pentraxin 1 expression and cell death induced by potassium deprivation in cerebellar granule cells. Mol. Pharmacol. 67, 1237–1246 (2005)

    Trullas R. , 'Glycogen synthase kinase 3 activity mediates neuronal pentraxin 1 expression and cell death induced by potassium deprivation in cerebellar granule cells ' (2005 ) 67 Mol. Pharmacol. : 1237 -1246.

    • Search Google Scholar
  • Fang ZY, Prins JB, Marwick TH: Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr. Rev. 25, 543–567 (2004)

    Marwick T.H. , 'Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications ' (2004 ) 25 Endocr. Rev. : 543 -567.

    • Search Google Scholar
  • Fernyhough P, Gallagher A, Averill SA, Priestley JV, Hounsom L, Patel J, Tomlinson DR: Aberrant neurofilament phosphorylation in sensory neurons of rats with diabetic neuropathy. Diabetes 48, 881–889 (1999)

    Tomlinson D.R. , 'Aberrant neurofilament phosphorylation in sensory neurons of rats with diabetic neuropathy ' (1999 ) 48 Diabetes : 881 -889.

    • Search Google Scholar
  • Finck BN, Han X, Courtois M, Aimond F, Nerbonne JM, Kovacs A, Gross RW, Kelly DP: A critical role for PPARalpha-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content. Proc. Natl. Acad. Sci. U. S. A. 100, 1226–1231 (2003)

    Kelly D.P. , 'A critical role for PPARalpha-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content ' (2003 ) 100 Proc. Natl. Acad. Sci. U. S. A. : 1226 -1231.

    • Search Google Scholar
  • Fiordaliso F, Li B, Latini R, Sonnenblick EH, Anversa P, Leri A, Kajstura J: Myocyte death in streptozotocin-induced diabetes in rats in angiotensin II-dependent. Lab. Invest. 80, 513–527 (2000)

    Kajstura J. , 'Myocyte death in streptozotocin-induced diabetes in rats in angiotensin II-dependent ' (2000 ) 80 Lab. Invest. : 513 -527.

    • Search Google Scholar
  • Francis GS: Diabetic cardiomyopathy: fact or fiction? Heart 85, 247–248 (2001)

    Francis G.S. , 'Diabetic cardiomyopathy: fact or fiction? ' (2001 ) 85 Heart : 247 -248.

  • Frustaci A, Kajstura J, Chimenti C, Jakoniuk I, Leri A, Maseri A, Nadal-Ginard B, Anversa P: Myocardial cell death in human diabetes. Circ. Res. 87, 1123–1132 (2000)

    Anversa P. , 'Myocardial cell death in human diabetes ' (2000 ) 87 Circ. Res. : 1123 -1132.

  • Fu H, Subramanian RR, Masters SC: 14-3-3 proteins: structure, function, and regulation. Annu. Rev. Pharmacol. Toxicol. 40, 617–647 (2000)

    Masters S.C. , '14-3-3 proteins: structure, function, and regulation ' (2000 ) 40 Annu. Rev. Pharmacol. Toxicol. : 617 -647.

    • Search Google Scholar
  • Giugliano D, Ceriello A, Paolisso G: Oxidative stress and diabetic vascular complications. Diabetes Care 19, 257–267 (1996)

    Paolisso G. , 'Oxidative stress and diabetic vascular complications ' (1996 ) 19 Diabetes Care : 257 -267.

    • Search Google Scholar
  • Gray MO, Long CS, Kalinyak JE, Li HT, Karliner JS: Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts. Cardiovasc. Res. 40, 352–363 (1998)

    Karliner J.S. , 'Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts ' (1998 ) 40 Cardiovasc. Res. : 352 -363.

    • Search Google Scholar
  • Grimm D, Jabusch HC, Kossmehl P, Huber M, Fredersdorf S, Griese DP, Kramer BK, Kromer EP: Experimental diabetes and left ventricular hypertrophy: effects of beta-receptor blockade. Cardiovasc. Pathol. 11, 229–237 (2002)

    Kromer E.P. , 'Experimental diabetes and left ventricular hypertrophy: effects of beta-receptor blockade ' (2002 ) 11 Cardiovasc. Pathol. : 229 -237.

    • Search Google Scholar
  • Gurusamy N, Watanabe K, Ma M, Prakash P, Hirabayashi K, Zhang S, Muslin AJ, Kodama M, Aizawa Y: Glycogen synthase kinase 3beta together with 14-3-3 protein regulates diabetic cardiomyopathy: effect of losartan and tempol. FEBS Lett. 580, 1932–1940 (2006)

    Aizawa Y. , 'Glycogen synthase kinase 3beta together with 14-3-3 protein regulates diabetic cardiomyopathy: effect of losartan and tempol ' (2006 ) 580 FEBS Lett. : 1932 -1940.

    • Search Google Scholar
  • Gurusamy N, Watanabe K, Ma M, Zhang S, Muslin AJ, Kodama M, Aizawa Y: Dominant negative 14-3-3 promotes cardiomyocyte apoptosis in early stage of type I diabetes mellitus through activation of JNK. Biochem. Biophys. Res. Commun. 320, 773–780 (2004)

    Aizawa Y. , 'Dominant negative 14-3-3 promotes cardiomyocyte apoptosis in early stage of type I diabetes mellitus through activation of JNK ' (2004 ) 320 Biochem. Biophys. Res. Commun. : 773 -780.

    • Search Google Scholar
  • Gurusamy N, Watanabe K, Ma M, Zhang S, Muslin AJ, Kodama M, Aizawa Y: Inactivation of 14-3-3 protein exacerbates cardiac hypertrophy and fibrosis through enhanced expression of protein kinase C beta 2 in experimental diabetes. Biol. Pharm. Bull. 28, 957–962 (2005)

    Aizawa Y. , 'Inactivation of 14-3-3 protein exacerbates cardiac hypertrophy and fibrosis through enhanced expression of protein kinase C beta 2 in experimental diabetes ' (2005 ) 28 Biol. Pharm. Bull. : 957 -962.

    • Search Google Scholar
  • Haneda M, Araki S, Togawa M, Sugimoto T, Isono M, Kikkawa R: Mitogen-activated protein kinase cascade is activated in glomeruli of diabetic rats and glomerular mesangial cells cultured under high glucose conditions. Diabetes 46, 847–853 (1997)

    Kikkawa R. , 'Mitogen-activated protein kinase cascade is activated in glomeruli of diabetic rats and glomerular mesangial cells cultured under high glucose conditions ' (1997 ) 46 Diabetes : 847 -853.

    • Search Google Scholar
  • Ho FM, Liu SH, Liau CS, Huang PJ, Lin-Shiau SY: High glucose-induced apoptosis in human endothelial cells is mediated by sequential activations of c-Jun NH(2)-terminal kinase and caspase-3. Circulation 101, 2618–2624 (2000)

    Lin-Shiau S.Y. , 'High glucose-induced apoptosis in human endothelial cells is mediated by sequential activations of c-Jun NH(2)-terminal kinase and caspase-3 ' (2000 ) 101 Circulation : 2618 -2624.

    • Search Google Scholar
  • Hoenack C, Roesen P: Inhibition of angiotensin type 1 receptor prevents decline of glucose transporter (GLUT4) in diabetic rat heart. Diabetes 45Suppl 1, S82–S87 (1996)

    Roesen P. , 'Inhibition of angiotensin type 1 receptor prevents decline of glucose transporter (GLUT4) in diabetic rat heart ' (1996 ) 45 Diabetes : S82 -S87.

    • Search Google Scholar
  • Inoguchi T, Sonta T, Tsubouchi H, Etoh T, Kakimoto M, Sonoda N, Sato N, Sekiguchi N, Kobayashi K, Sumimoto H, Utsumi H, Nawata H: Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD(P)H oxidase. J. Am. Soc. Nephrol. 14, S227–S232 (2003)

    Nawata H. , 'Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD(P)H oxidase ' (2003 ) 14 J. Am. Soc. Nephrol. : S227 -S232.

    • Search Google Scholar
  • Kajstura J, Fiordaliso F, Andreoli AM, Li B, Chimenti S, Medow MS, Limana F, Nadal-Ginard B, Leri A, Anversa P: IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress. Diabetes 50, 1414–1424 (2001)

    Anversa P. , 'IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress ' (2001 ) 50 Diabetes : 1414 -1424.

    • Search Google Scholar
  • Kang YJ: Molecular and cellular mechanisms of cardiotoxicity. Environ. Health Perspect. 109Suppl 1, 27–34 (2001)

    Kang Y.J. , 'Molecular and cellular mechanisms of cardiotoxicity ' (2001 ) 109 Environ. Health Perspect. : 27 -34.

    • Search Google Scholar
  • Kim S, Wanibuchi H, Hamaguchi A, Miura K, Yamanaka S, Iwao H: Angiotensin blockade improves cardiac and renal complications of type II diabetic rats. Hypertension 30, 1054–1061 (1997)

    Iwao H. , 'Angiotensin blockade improves cardiac and renal complications of type II diabetic rats ' (1997 ) 30 Hypertension : 1054 -1061.

    • Search Google Scholar
  • Kralik PM, Ye G, Metreveli NS, Shem X, Epstein PN: Cardiomyocyte dysfunction in models of type 1 and type 2 diabetes. Cardiovasc. Toxicol. 5, 285–292 (2005)

    Epstein P.N. , 'Cardiomyocyte dysfunction in models of type 1 and type 2 diabetes ' (2005 ) 5 Cardiovasc. Toxicol. : 285 -292.

    • Search Google Scholar
  • Kupfahl C, Pink D, Friedrich K, Zurbrugg HR, Neuss M, Warnecke C, Fielitz J, Graf K, Fleck E, Regitz-Zagrosek V: Angiotensin II directly increases transforming growth factor beta1 and osteopontin and indirectly affects collagen mRNA expression in the human heart. Cardiovasc. Res. 46, 463–475 (2000)

    Regitz-Zagrosek V. , 'Angiotensin II directly increases transforming growth factor beta1 and osteopontin and indirectly affects collagen mRNA expression in the human heart ' (2000 ) 46 Cardiovasc. Res. : 463 -475.

    • Search Google Scholar
  • Kurtz TW, Pravenec M: Antidiabetic mechanisms of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists: beyond the renin-angiotensin system. J. Hypertens. 22, 2253–2261 (2004)

    Pravenec M. , 'Antidiabetic mechanisms of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists: beyond the renin-angiotensin system ' (2004 ) 22 J. Hypertens. : 2253 -2261.

    • Search Google Scholar
  • Lassila M, Davis BJ, Allen TJ, Burrell LM, Cooper ME, Cao Z: Cardiovascular hypertrophy in diabetic spontaneously hypertensive rats: optimizing blockade of the renin-angiotensin system. Clin. Sci. (Lond). 104, 341–347 (2003)

    Cao Z. , 'Cardiovascular hypertrophy in diabetic spontaneously hypertensive rats: optimizing blockade of the renin-angiotensin system ' (2003 ) 104 Clin. Sci. (Lond) : 341 -347.

    • Search Google Scholar
  • Lee JC, Downing SE: Ventricular performance in diabetic rabbits with norepinephrine cardiomyopathy. Proc. Soc. Exp. Biol. Med. 181, 345–350 (1986)

    Downing S.E. , 'Ventricular performance in diabetic rabbits with norepinephrine cardiomyopathy ' (1986 ) 181 Proc. Soc. Exp. Biol. Med. : 345 -350.

    • Search Google Scholar
  • Lekli I, Szabo G, Juhasz B, Das S, Das M, Varga E, Szendrei L, Gesztelyi R, Varadi J, Bak I, Das DK, Tosaki A: Protective mechanisms of resveratrol against ischemia-reperfusion-induced damage in hearts obtained from Zucker obese rats: the role of GLUT-4 and endothelin. Am. J. Physiol. Heart Circ. Physiol. 294, H859–H866 (2008)

    Tosaki A. , 'Protective mechanisms of resveratrol against ischemia-reperfusion-induced damage in hearts obtained from Zucker obese rats: the role of GLUT-4 and endothelin ' (2008 ) 294 Am. J. Physiol. Heart Circ. Physiol. : H859 -H866.

    • Search Google Scholar
  • Li X, Xu Z, Li S, Rozanski GJ: Redox regulation of Ito remodeling in diabetic rat heart. Am. J. Physiol. Heart Circ. Physiol. 288, H1417–H1424 (2005)

    Rozanski G.J. , 'Redox regulation of Ito remodeling in diabetic rat heart ' (2005 ) 288 Am. J. Physiol. Heart Circ. Physiol. : H1417 -H1424.

    • Search Google Scholar
  • Liao W, Wang S, Han C, Zhang Y: 14-3-3 proteins regulate glycogen synthase 3beta phosphorylation and inhibit cardiomyocyte hypertrophy. FEBS J. 272, 1845–1854 (2005)

    Zhang Y. , '14-3-3 proteins regulate glycogen synthase 3beta phosphorylation and inhibit cardiomyocyte hypertrophy ' (2005 ) 272 FEBS J. : 1845 -1854.

    • Search Google Scholar
  • Ligeti L, Szenczi O, Prestia CM, Szabo C, Horvath K, Marcsek ZL, van Stiphout RG, van Riel NA, Op den Buijs J, Van der Vusse GJ, Ivanics T: Altered calcium handling is an early sign of streptozotocin-induced diabetic cardiomyopathy. Int. J. Mol. Med. 17, 1035–1043 (2006)

    Ivanics T. , 'Altered calcium handling is an early sign of streptozotocin-induced diabetic cardiomyopathy ' (2006 ) 17 Int. J. Mol. Med. : 1035 -1043.

    • Search Google Scholar
  • Liu W, Schoenkerman A, Lowe WL Jr.: Activation of members of the mitogen-activated protein kinase family by glucose in endothelial cells. Am. J. Physiol. Endocrinol. Metab. 279, E782–E790 (2000)

    Lowe W.L. , 'Activation of members of the mitogen-activated protein kinase family by glucose in endothelial cells ' (2000 ) 279 Am. J. Physiol. Endocrinol. Metab. : E782 -E790.

    • Search Google Scholar
  • Lorell BH, Carabello BA: Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation 102, 470–490 (2000)

    Carabello B.A. , 'Left ventricular hypertrophy: pathogenesis, detection, and prognosis ' (2000 ) 102 Circulation : 470 -490.

    • Search Google Scholar
  • Machackova J, Liu X, Lukas A, Dhalla NS: Renin-angiotensin blockade attenuates cardiac myofibrillar remodelling in chronic diabetes. Mol. Cell. Biochem. 261, 271–278 (2004)

    Dhalla N.S. , 'Renin-angiotensin blockade attenuates cardiac myofibrillar remodelling in chronic diabetes ' (2004 ) 261 Mol. Cell. Biochem. : 271 -278.

    • Search Google Scholar
  • Mullarkey CJ, Edelstein D, Brownlee M: Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochem. Biophys. Res. Commun. 173, 932–939 (1990)

    Brownlee M. , 'Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes ' (1990 ) 173 Biochem. Biophys. Res. Commun. : 932 -939.

    • Search Google Scholar
  • Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404, 787–790 (2000)

    Brownlee M. , 'Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage ' (2000 ) 404 Nature : 787 -790.

    • Search Google Scholar
  • Nunoda S, Genda A, Sugihara N, Nakayama A, Mizuno S, Takeda R: Quantitative approach to the histopathology of the biopsied right ventricular myocardium in patients with diabetes mellitus. Heart Vessels 1, 43–47 (1985)

    Takeda R. , 'Quantitative approach to the histopathology of the biopsied right ventricular myocardium in patients with diabetes mellitus ' (1985 ) 1 Heart Vessels : 43 -47.

    • Search Google Scholar
  • Pang Y, Hunton DL, Bounelis P, Marchase RB: Hyperglycemia inhibits capacitative calcium entry and hypertrophy in neonatal cardiomyocytes. Diabetes 51, 3461–3467 (2002)

    Marchase R.B. , 'Hyperglycemia inhibits capacitative calcium entry and hypertrophy in neonatal cardiomyocytes ' (2002 ) 51 Diabetes : 3461 -3467.

    • Search Google Scholar
  • Passier R, Zeng H, Frey N, Naya FJ, Nicol RL, McKinsey TA, Overbeek P, Richardson JA, Grant SR, Olson EN: CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo. J. Clin. Invest. 105, 1395–1406 (2000)

    Olson E.N. , 'CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo ' (2000 ) 105 J. Clin. Invest. : 1395 -1406.

    • Search Google Scholar
  • Penumathsa SV, Thirunavukkarasu M, Samuel SM, Zhan L, Maulik G, Bagchi M, Bagchi D, Maulik N: Niacin bound chromium treatment induces myocardial Glut-4 translocation and caveolar interaction via Akt, AMPK and eNOS phosphorylation in streptozotocin induced diabetic rats after ischemia-reperfusion injury. Biochim. Biophys. Acta 1792, 39–48 (2009)

    Maulik N. , 'Niacin bound chromium treatment induces myocardial Glut-4 translocation and caveolar interaction via Akt, AMPK and eNOS phosphorylation in streptozotocin induced diabetic rats after ischemia-reperfusion injury ' (2009 ) 1792 Biochim. Biophys. Acta : 39 -48.

    • Search Google Scholar
  • Pozuelo Rubio M, Geraghty KM, Wong BH, Wood NT, Campbell DG, Morrice N, Mackintosh C: 14-3-3-affinity purification of over 200 human phosphoproteins reveals new links to regulation of cellular metabolism, proliferation and trafficking. Biochem. J. 379, 395–408 (2004)

    Mackintosh C. , '14-3-3-affinity purification of over 200 human phosphoproteins reveals new links to regulation of cellular metabolism, proliferation and trafficking ' (2004 ) 379 Biochem. J. : 395 -408.

    • Search Google Scholar
  • Privratsky JR, Wold LE, Sowers JR, Quinn MT, Ren J: AT1 blockade prevents glucose-induced cardiac dysfunction in ventricular myocytes: role of the AT1 receptor and NADPH oxidase. Hypertension 42, 206–212 (2003)

    Ren J. , 'AT1 blockade prevents glucose-induced cardiac dysfunction in ventricular myocytes: role of the AT1 receptor and NADPH oxidase ' (2003 ) 42 Hypertension : 206 -212.

    • Search Google Scholar
  • Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG: Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J. Clin. Invest. 97, 1916–1923 (1996)

    Harrison D.G. , 'Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone ' (1996 ) 97 J. Clin. Invest. : 1916 -1923.

    • Search Google Scholar
  • Roberts MR: Regulatory 14-3-3 protein-protein interactions in plant cells. Curr. Opin. Plant Biol. 3, 400–405 (2000)

    Roberts M.R. , 'Regulatory 14-3-3 protein-protein interactions in plant cells ' (2000 ) 3 Curr. Opin. Plant Biol. : 400 -405.

    • Search Google Scholar
  • Robinson K, Jones D, Patel Y, Martin H, Madrazo J, Martin S, Howell S, Elmore M, Finnen MJ, Aitken A: Mechanism of inhibition of protein kinase C by 14-3-3 isoforms. 14-3-3 isoforms do not have phospholipase A2 activity. Biochem. J. 299 (Pt 3), 853–861 (1994)

    Aitken A. , 'Mechanism of inhibition of protein kinase C by 14-3-3 isoforms. 14-3-3 isoforms do not have phospholipase A2 activity ' (1994 ) 299 Biochem. J. : 853 -861.

    • Search Google Scholar
  • Shimizu M, Umeda K, Sugihara N, Yoshio H, Ino H, Takeda R, Okada Y, Nakanishi I: Collagen remodelling in myocardia of patients with diabetes. J. Clin. Pathol. 46, 32–36 (1993)

    Nakanishi I. , 'Collagen remodelling in myocardia of patients with diabetes ' (1993 ) 46 J. Clin. Pathol. : 32 -36.

    • Search Google Scholar
  • Sugden PH, Clerk A: Cellular mechanisms of cardiac hypertrophy. J. Mol. Med. 76, 725–746 (1998)

    Clerk A. , 'Cellular mechanisms of cardiac hypertrophy ' (1998 ) 76 J. Mol. Med. : 725 -746.

  • Szendrei L, Turoczi T, Kovacs P, Vecsernyes M, Das DK, Tosaki A: Mitochondrial gene expression and ventricular fibrillation in ischemic/reperfused nondiabetic and diabetic myocardium. Biochem. Pharmacol. 63, 543–552 (2002)

    Tosaki A. , 'Mitochondrial gene expression and ventricular fibrillation in ischemic/reperfused nondiabetic and diabetic myocardium ' (2002 ) 63 Biochem. Pharmacol. : 543 -552.

    • Search Google Scholar
  • Thandavarayan RA, Watanabe K, Ma M, Veeraveedu PT, Gurusamy N, Palaniyandi SS, Zhang S, Muslin AJ, Kodama M, Aizawa Y: 14-3-3 protein regulates Ask1 signaling and protects against diabetic cardiomyopathy. Biochem. Pharmacol. 75, 1797–1806 (2008)

    Aizawa Y. , '14-3-3 protein regulates Ask1 signaling and protects against diabetic cardiomyopathy ' (2008 ) 75 Biochem. Pharmacol. : 1797 -1806.

    • Search Google Scholar
  • Thirunavukkarasu M, Penumathsa SV, Koneru S, Juhasz B, Zhan L, Otani H, Bagchi D, Das DK, Maulik N: Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin, and heme oxygenase. Free Radic. Biol. Med. 43, 720–729 (2007)

    Maulik N. , 'Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin, and heme oxygenase ' (2007 ) 43 Free Radic. Biol. Med. : 720 -729.

    • Search Google Scholar
  • Tomita H, Egashira K, Ohara Y, Takemoto M, Koyanagi M, Katoh M, Yamamoto H, Tamaki K, Shimokawa H, Takeshita A: Early induction of transforming growth factor-beta via angiotensin II type 1 receptors contributes to cardiac fibrosis induced by long-term blockade of nitric oxide synthesis in rats. Hypertension 32, 273–279 (1998)

    Takeshita A. , 'Early induction of transforming growth factor-beta via angiotensin II type 1 receptors contributes to cardiac fibrosis induced by long-term blockade of nitric oxide synthesis in rats ' (1998 ) 32 Hypertension : 273 -279.

    • Search Google Scholar
  • Tomita M, Mukae S, Geshi E, Umetsu K, Nakatani M, Katagiri T: Mitochondrial respiratory impairment in streptozotocin-induced diabetic rat heart. Jpn. Circ. J. 60, 673–682 (1996)

    Katagiri T. , 'Mitochondrial respiratory impairment in streptozotocin-induced diabetic rat heart ' (1996 ) 60 Jpn. Circ. J. : 673 -682.

    • Search Google Scholar
  • Tosaki A, Pali T, Droy-Lefaix MT: Effects of Ginkgo biloba extract and preconditioning on the diabetic rat myocardium. Diabetologia 39, 1255–1262 (1996)

    Droy-Lefaix M.T. , 'Effects of Ginkgo biloba extract and preconditioning on the diabetic rat myocardium ' (1996 ) 39 Diabetologia : 1255 -1262.

    • Search Google Scholar
  • Tzivion G, Shen YH, Zhu J: 14-3-3 proteins; bringing new definitions to scaffolding. Oncogene 20, 6331–6338 (2001)

    Zhu J. , '14-3-3 proteins; bringing new definitions to scaffolding ' (2001 ) 20 Oncogene : 6331 -6338.

    • Search Google Scholar
  • van Hemert MJ, Steensma HY, van Heusden GP: 14-3-3 proteins: key regulators of cell division, signalling and apoptosis. Bioessays 23, 936–946 (2001)

    Heusden G.P. , '14-3-3 proteins: key regulators of cell division, signalling and apoptosis ' (2001 ) 23 Bioessays : 936 -946.

    • Search Google Scholar
  • Wang W, Shakes DC: Molecular evolution of the 14-3-3 protein family. J. Mol. Evol. 43, 384–398 (1996)

    Shakes D.C. , 'Molecular evolution of the 14-3-3 protein family ' (1996 ) 43 J. Mol. Evol. : 384 -398.

    • Search Google Scholar
  • Way KJ, Isshiki K, Suzuma K, Yokota T, Zvagelsky D, Schoen FJ, Sandusky GE, Pechous PA, Vlahos CJ, Wakasaki H, King GL: Expression of connective tissue growth factor is increased in injured myocardium associated with protein kinase C beta2 activation and diabetes. Diabetes 51, 2709–2718 (2002)

    King G.L. , 'Expression of connective tissue growth factor is increased in injured myocardium associated with protein kinase C beta2 activation and diabetes ' (2002 ) 51 Diabetes : 2709 -2718.

    • Search Google Scholar
  • Wilker E, Yaffe MB: 14-3-3 Proteins: a focus on cancer and human disease. J. Mol. Cell. Cardiol. 37, 633–642 (2004)

    Yaffe M.B. , '14-3-3 Proteins: a focus on cancer and human disease ' (2004 ) 37 J. Mol. Cell. Cardiol. : 633 -642.

    • Search Google Scholar
  • Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Kawamura T, Nyengaard JR, van den Enden M, Kilo C, Tilton RG: Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42, 801–813 (1993)

    Tilton R.G. , 'Hyperglycemic pseudohypoxia and diabetic complications ' (1993 ) 42 Diabetes : 801 -813.

    • Search Google Scholar
  • Xing H, Zhang S, Weinheimer C, Kovacs A, Muslin AJ: 14-3-3 proteins block apoptosis and differentially regulate MAPK cascades. EMBO J. 19, 349–358 (2000)

    Muslin A.J. , '14-3-3 proteins block apoptosis and differentially regulate MAPK cascades ' (2000 ) 19 EMBO J. : 349 -358.

    • Search Google Scholar
  • Yin H, Chao L, Chao J: Kallikrein/kinin protects against myocardial apoptosis after ischemia/reperfusion via Akt-glycogen synthase kinase-3 and Akt-Bad.14-3-3 signaling pathways. J. Biol. Chem. 280, 8022–8030 (2005)

    Chao J. , 'Kallikrein/kinin protects against myocardial apoptosis after ischemia/reperfusion via Akt-glycogen synthase kinase-3 and Akt-Bad.14-3-3 signaling pathways ' (2005 ) 280 J. Biol. Chem. : 8022 -8030.

    • Search Google Scholar
  • Zaman AK, Fujii S, Goto D, Furumoto T, Mishima T, Nakai Y, Dong J, Imagawa S, Sobel BE, Kitabatake A: Salutary effects of attenuation of angiotensin II on coronary perivascular fibrosis associated with insulin resistance and obesity. J. Mol. Cell. Cardiol. 37, 525–535 (2004)

    Kitabatake A. , 'Salutary effects of attenuation of angiotensin II on coronary perivascular fibrosis associated with insulin resistance and obesity ' (2004 ) 37 J. Mol. Cell. Cardiol. : 525 -535.

    • Search Google Scholar

The author instruction is available in PDF.

Please, download the file from HERE

Senior editors

Editor(s)-in-Chief: Rosivall, László

Honorary Editor(s)-in-Chief): Monos, Emil

Managing Editor(s): Bartha, Jenő; Berhidi, Anna

Co-editor(s): Koller, Ákos; Lénárd, László; Szénási, Gábor

Assistant Editor(s): G. Dörnyei (Budapest), Zs. Miklós (Budapest), Gy. Nádasy (Budapest)

Hungarian Editorial Board

      Benedek, György (Szeged)
      Benyó, Zoltán (Budapest)
      Boros, Mihály (Szeged)
      Chernoch, László (Debrecen)
      Détári, László (Budapest)
      Hamar, János (Budapest)
      Hantos, Zoltán (Szeged)
      Hunyady, László (Budapest)
      Imre, Sándor (Debrecen)
      Jancsó, Gábor (Szeged)
      Karádi, Zoltán (Pécs)
      Kovács, László (Debrecen)
      Palkovits, Miklós (Budapest)
      Papp, Gyula (Szeged)
      Pavlik, Gábor (Budapest)
      Spät, András (Budapest)
      Szabó, Gyula (Szeged)
      Szelényi, Zoltán (Pécs)
      Szolcsányi, János (Pécs)
      Szollár, Lajos (Budapest)
      Szücs, Géza (Debrecen)
      Telegdy, Gyula (Szeged)
      Toldi, József (Szeged)
      Tósaki, Árpád (Debrecen)

International Editorial Board

      R. Bauer (Jena)
      W. Benjelloun (Rabat)
      A. W. Cowley Jr. (Milwaukee)
      D. Djuric (Belgrade)
      C. Fry (London)
      S. Greenwald (London)
      O. Hänninen (Kuopio)
      H. G. Hinghofer-Szalkay (Graz)
      Th. Kenner (Graz)
      Gy. Kunos (Richmond)
      M. Mahmoudian (Tehran)
      T. Mano (Seki, Gifu)
      G. Navar (New Orleans)
      H. Nishino (Nagoya)
      O. Petersen (Liverpool)
      U. Pohl (Münich)
      R. S. Reneman (Maastricht)
      A. Romanovsky (Phoenix)
      G. M. Rubanyi (Richmond)
      T. Sakata (Oita)
      A. Siddiqui (Karachi)
      Cs. Szabo (Beverly)
      E. Vicaut (Paris)
      N. Westerhof (Amsterdam)
      L. F. Zhang (Xi'an)

Editorial Office:
Akadémiai Kiadó Zrt.
Prielle Kornélia u. 21–35, H-1117 Budapest, Hungary

Editorial Correspondence:
Acta Physiologica Hungarica
Semmelweis University, Faculty of Medicine Institute of Pathophysiology
Nagyvárad tér 4, H-1089 Budapest, Hungary
Phone/Fax: +36-1-2100-100
E-mail: aph@semmelweis-univ.hu

Indexing and Abstracting Services:

  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • Chemical Abstracts
  • EMBASE/Excerpta Medica
  • Global Health
  • Index Copernicus
  • Index Medicus
  • Medline
  • Referativnyi Zhurnal
  • Science Citation Index Expanded
  • SCOPUS

 

Acta Physiologica Hungarica
Language English
Size  
Year of
Foundation
1950
Publication
Programme
changed title
Volumes
per Year
 
Issues
per Year
 
Founder Magyar Tudományos Akadémia
Founder's
Address
H-1051 Budapest, Hungary, Széchenyi István tér 9.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 0231-424X (Print)
ISSN 1588-2683 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
May 2021 6 0 0
Jun 2021 14 0 0
Jul 2021 16 0 0
Aug 2021 16 0 0
Sep 2021 23 0 0
Oct 2021 13 0 0
Nov 2021 0 0 0